| Literature DB >> 35890563 |
Jie Zhang1, Jing Wang1, Guixiu Fan1,2, Bingjie Zhang1, Guanglong Ma3, Haiyan Xiao1, Longgang Wang1,2.
Abstract
Silver nanoparticles as photothermal agents have the problems of low stability and low photothermal conversion efficiency. Amphiphilic daptomycin can improve the stability of silver nanoparticles, thereby improving their photothermal conversion efficiency. Herein, daptomycin-biomineralized silver nanoparticles (Dap-AgNPs) were prepared by reducing silver nitrate with sodium borohydride in the presence of daptomycin as a stabilizer and biomineralizer. The Dap-AgNPs had good solution stability and peroxidase-like activity. Furthermore, the photothermal conversion efficiency of the Dap-AgNPs was as high as 36.8%. The Dap-AgNPs displayed good photothermal stability under irradiation. More importantly, the Dap-AgNPs showed good cell compatibility with HeLa cells and HT-29 cells without irradiation by 808-nanometer near-infrared light at a concentration of 0.5 mM, and the cell viability was greater than 85.0%. However, the Dap-AgNPs displayed significant anti-tumor ability with irradiation by 808-nanometer near-infrared light, which was due to the increasing temperature of the culture medium caused by the Dap-AgNPs. In conclusion, Dap-AgNPs have potential applications as photothermal agents in the treatment of tumors.Entities:
Keywords: anti-tumor; biocompatibility; biomineralization; daptomycin; silver nanoparticle
Year: 2022 PMID: 35890563 PMCID: PMC9322905 DOI: 10.3390/polym14142787
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Scheme 1The preparation and application of stable daptomycin-biomineralized silver nanoparticles (Dap-AgNPs).
Figure 1(A) The UV-Vis absorption spectra of sample solution; (B) transmission electron micrograph of Dap-AgNPs.
Figure 2(A) Hydrodynamic size of each sample in solution and (B) zeta potential of Dap-AgNPs in different pH solutions.
Figure 3(A) EDS pattern and (B) XRD pattern of Dap-AgNPs.
Figure 4(A) UV-Vis absorption spectra of (1) TMB + H2O2; (2) TMB + Dap-AgNPs; (3) TMB + H2O2+ Dap-AgNPs; (4) H2O2 + Dap-AgNPs; (B) photographs of (A).
Figure 5(A) The temperature of the sample solution irradiated with the 808-nanometer laser at 1.75 W/cm2 for 10 min; (B) the Dap-AgNPs solution irradiated with the 808-nanometer laser at 1.75 W/cm2 to reach maximum temperature and then cool down naturally; (C) temperature profile of Dap-AgNP solution during five cycles of laser irradiation.
Figure 6The biocompatibility of the sample to (A) HeLa cells and (B) HT-29 cells.
Figure 7Pictures of HeLa cell stained by FDA (100 μg/mL) and PI (60 μg/mL) to observe the effects of each sample on the cells.